1. Home
  2. CDIO vs SANW Comparison

CDIO vs SANW Comparison

Compare CDIO & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • SANW
  • Stock Information
  • Founded
  • CDIO 2017
  • SANW 1980
  • Country
  • CDIO United States
  • SANW United States
  • Employees
  • CDIO N/A
  • SANW N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • SANW Farming/Seeds/Milling
  • Sector
  • CDIO Health Care
  • SANW Consumer Staples
  • Exchange
  • CDIO Nasdaq
  • SANW Nasdaq
  • Market Cap
  • CDIO 19.5M
  • SANW 18.8M
  • IPO Year
  • CDIO N/A
  • SANW 2010
  • Fundamental
  • Price
  • CDIO $4.53
  • SANW $5.52
  • Analyst Decision
  • CDIO Buy
  • SANW Strong Buy
  • Analyst Count
  • CDIO 1
  • SANW 1
  • Target Price
  • CDIO $2.00
  • SANW $35.00
  • AVG Volume (30 Days)
  • CDIO 68.6K
  • SANW 9.5K
  • Earning Date
  • CDIO 05-23-2025
  • SANW 05-20-2025
  • Dividend Yield
  • CDIO N/A
  • SANW N/A
  • EPS Growth
  • CDIO N/A
  • SANW N/A
  • EPS
  • CDIO N/A
  • SANW N/A
  • Revenue
  • CDIO $34,890.00
  • SANW $54,809,365.00
  • Revenue This Year
  • CDIO $1,434.82
  • SANW N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • SANW $14.25
  • P/E Ratio
  • CDIO N/A
  • SANW N/A
  • Revenue Growth
  • CDIO 104.45
  • SANW N/A
  • 52 Week Low
  • CDIO $0.19
  • SANW $2.10
  • 52 Week High
  • CDIO $1.77
  • SANW $11.60
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 29.92
  • SANW 49.54
  • Support Level
  • CDIO $4.50
  • SANW $5.03
  • Resistance Level
  • CDIO $14.46
  • SANW $5.76
  • Average True Range (ATR)
  • CDIO 1.69
  • SANW 0.76
  • MACD
  • CDIO -0.97
  • SANW 0.12
  • Stochastic Oscillator
  • CDIO 4.66
  • SANW 42.41

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About SANW S&W Seed Company (NV)

S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.

Share on Social Networks: